In the Lab By Sharon Begley Macular degeneration trial will be first human test in U.S. of Nobel-winning stem cell technique
In the Lab By Rebecca Robbins A daredevil researcher’s latest quest: to restore sight lost to glaucoma using virtual reality
In the Lab By Sharon Begley A CRISPR trick in blind mice points the way to possible treatments for inherited diseases
Biotech By Robert Weisman — Boston Globe Research into new macular degeneration treatments takes off as cases steadily rise
Medical Mystery By Allison Bond This 6-year-old suddenly had trouble reading. Why was she going blind?
In the Lab By Casey Ross Opening the ‘black box,’ Google DeepMind AI system diagnoses eye diseases and shows its work
Pharmalot By Ed Silverman Novartis employee claims she was fired for complaining about incorrect data
In the Lab By Sharon Begley Scientists show mice an Orson Welles movie, then disprove dogma about how vision works
Health Tech By Lauren Joseph 5 burning questions about using artificial intelligence to prevent blindness
In the Lab By Orly Nadell Farber Glaucoma may be an autoimmune disease, study finds, suggesting new treatment approaches
Special Report By Eric Boodman The Amish pool resources for their medical care. A budget-busting gene therapy puts them in a bind
In the Lab By Andrew Joseph Early trials of stem-cell therapies hint at potential to restore some vision
Biotech By Andrew Joseph At $850,000, price for new childhood blindness gene therapy four times too high, analysis says
Health By Rebecca Robbins ‘What the 21st century demands’: designing homes to improve patients’ health
Health By Charles Piller Google Glass is back — as a tool to coach autistic children, train doctors, and more
Boddities By Megan Thielking Watch: Episode 12: What would happen to your eyes if you looked at the solar eclipse?